As per revised definition proposed to US FDA, Effervescent tablet is a tablet intended to be dissolved or dispersed in water before administration. In addition to active ingredients, it generally contains mixture of acids/acid salts and carbonate and hydrogen carbonates which release carbon dioxide when mixed with water. 2 Effervescence is the evolution of gas bubbles from a liquid, as the result of a chemical reaction. This reaction occurs in presence of water, even with small amount as catalyzing agent, and because water is one of the reaction products, it accelerates the rate of reaction, leading to difficulty in stopping the reaction. For this reason, the whole manufacturing and storage of effervescent products is planned by minimizing the contact with water. 3 Alendronate sodium is a BCS class III bisphosphonate, used in the treatment of osteoporosis. 5, 6 Which acts as a potent, specific inhibitor of osteoclast-mediated bone resorption. 4 Colecalciferol (vitamin D
) is a secosterol that is the natural precursor of the calcium-regulating hormone calcitriol (1,25-dihydroxyvitamin D 3 ). 7 Peter C. P. et al.,
examine the possible mechanism for the esophageal adverse events reported with alendronate sodium tablets and the animal studies showed that under low pH conditions alendronate sodium can cause esophageal irritation. 8 This study seeks to formulate effervescent tablet of Alendronate sodium with cholecalciferol, which limits the amount of time in which the bisphosphonate is in contact with the Oesophageal tissue, thus minimizing the risk of irritation 9 and provide vitamin D 3 nutrition during bisphosphonate treatment to facilitate normal bone
ABSTRACT:
Alendronate sodium is a bisphosphonates which has antiresorptive effect which is implicated in the prophylaxis and treatment of osteoporosis. The objective of this study was to formulate effervescent tablet of Alendronate sodium with Vitamin D 3 against osteoporosis thereby improving patient compliance. As per revised definition proposed to US FDA, Effervescent tablet is a tablet intended to be dissolved or dispersed in water before administration. Effervescent tablets were formulated using citric acid and sodium bicarbonate as effervescent composition by wet granulation. The drug-excipient compatibility study done by DSC & FTIR analysis and it reveals absence of interaction between the drug and excipients. The flowability study of precompression blend shows good flow properties. 
METHODS:

I. DRUG-EXCIPIENT COMPATIBILITY STUDY:
Drug-Excipient Compatibility Study by FTIR:
The IR spectrum of drug as well as sample (drug and excipient) was recorded using FTIR spectrophotometer (Bruker, ALPHA, ECO-ATR) with diffuse reflectance principle.
Sample was placed in the sample holder and the spectrum was scanned over a frequency range 4000-400 cm -1 .
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Drug-Excipient Compatibility Study by DSC:
The DSC study was carried out using Mettler Toledo DSC 822e differential scanning calorimeter with thermal analyzer. The samples (drug and excipients) were heated in sealed aluminum pans under nitrogen flow (20 ml/min) at a scanning rate of 10°C/min from 0 to 300°C. Empty aluminum pan was used as a reference. The heat flow as a function of temperature was measured for the samples. 
III. EVALUATION OF PRECOMPRESSION BLEND:
1) Angle of repose:
It was measured by fixed funnel method. The fixed funnel method employ a funnel that was secured with its tip at a
given height "h", above graph paper that was placed on a flat horizontal surface. Granules were carefully poured through the funnel until the apex of the conical pile just touches the tip of the funnel. Thus, with "r" being the radius of the base of the conical pile.
14 tan θ = h / r
Where, θ= angle of repose 2) Bulk density: an accurately weighed sample of granulation was carefully added to the measuring cylinder with the aid of funnel. The level was observed without compacting and noted as apparent volume (V 0 ).
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The bulk density was calculated by the formula as given below:
Where, M=Mass of powder taken. V 0 = Apparent untapped volume.
3) Tapped density: After bulk density measurement the cylinder was placed on the tapped density tester (ETD 1060, Electrolab) and was mechanically tapped. The cylinder was tapped for 500 times initially and the tapped volume (V 1 ) was measured to the nearest graduated units.
The tapping was repeated for additional 750 times and the tapped volume (V 2 ) nearest to graduated units was noted. 15 The tapped density was calculated by the formula as given below:
Where, M= Weight of powder. V 2 = Tapped volume (after 750 taps).
4) Carr's Index:
The percentage compressibility of a powder is direct measure of the potential of powder arch or bridge strength is calculated according to the equation given below: [14] [15] [16] 5) Hausner's ratio: Hausner found that the ratio tapped density/bulk density was related to inter particle friction as such, could be used to predict powder flow properties.
The Hausner"s ratio was calculated by the formula as given below:
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IV. EVALUATION OF FORMULATION:
1) Tablet Dimensions:
Ten tablets of each formulation were evaluated for thickness and diameter using a calibrated dial caliper. 
2) Weight Variation:
Twenty tablets were selected randomly. Tablets were weighed individually and average weight was calculated.
Then deviation of each tablet from average weight was calculated and percent deviation was computed. 
3) Tablet Hardness:
The hardness was evaluated using Monsanto (VHT1,Veego) hardness tester. 
II. DRUG-EXCIPIENT COMPATIBILITY STUDY:
DSC Analysis Figure 2: DSC thermogram of Alendronate sodium
The DSC thermogram of Alendronate sodium (figure 2), showed an endothermic peak in the temperature region from 76⁰C to 115⁰C. It is followed by an irregular endothermic peak with shoulders at 135.46⁰C that corresponds to loss of coordinated and crystal water. The third endothermic peak, corresponding to melting of the drug is at 261⁰C. 
All values are expressed as mean ± SD (n=3)
IV. EVALUATION OF FORMULATION:
Preparation of standard calibration curve of Alendronate sodium: Figure 9 : UV-spectrum of Alendronate sodium in distilled water 
V. STABILITY STUDIES:
All values are expressed as mean ± SD (n=3)
DISCUSSION:
The procured sample of Alendronate sodium and Vitamin From the stability study results it was observed that there was no significant change in physiochemical properties even after storage at various temperature and humidity conditions for three months. It may be inferred that there was no degradation and change in the formulation.
CONCLUSIONS:
The 
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